Milestone begins Canadian enrolment in Phase III AFib-RVR trial

Milestone Pharmaceuticals has enrolled the first Canadian participant in its ongoing multinational Phase III clinical trial, ReVeRA-301. The post Milestone begins Canadian enrolment in Phase III AFib-RVR trial appeared first on Clinical Tri…

Summary from Clinical Trials Arena.

Coverage 1 article · 1 outlet

1. Clinical Trials Arena 3h ago
   Milestone begins Canadian enrolment in Phase III AFib-RVR trial ↗